ReviewCureus2026

Gatekeepers of Pain: A Scoping Review on How Nanoparticle Engineering Illuminates Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Targeting.

Alexa Q Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.